PLAGL2 and hepatocellular carcinoma: The lncRNA MAPKAPK5-AAS1 sponges miR-154-5p to upregulate PLAGL2 expression, thereby activating the EGFR/AKT signaling pathway to promote EMT progression in HCC [25].